Levels of investment and pipeline activity in infectious diseases have historically trailed other areas due to development and commercialization challenges. However, the COVID-19 pandemic has brought infectious diseases back to the forefront, and a recent surge of investments has transformed the current landscape. Is this attention on infectious diseases an isolated spike, or will it continue into the post-pandemic era? In this webinar, ZS Principal Cody Powers and other industry experts assess the state of the infectious diseases landscape, focusing on investment, development, commercialization, and policy. This session was part of the 2021 LSX World Congress, held February 1-5.